Immune response mechanisms to infections;Mecanismos de resposta imune às infecções

Anais Brasileiros de Dermatologia

Volumn 79, Issue 6, 2004, Pages 647-664

  Machado, Paulo R L ^a,b,c   Carvalho, Lucas ^a   Araújo, Maria Ilma A S ^a,b,c   Carvalho, Edgar M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Fund Baiana o Desenvolvimento Cie   (Brazil)

^c Immunology Service ^*  (Brazil)

Author keywords

Bacterial infections; Helminthiasis; Immunity; Immunity, natural; Infection immunology; Mycoses; Protozoan infections; Virus diseases

Indexed keywords

BACTERIAL INFECTION; CELL PROTECTION; COMPLEMENT DEFICIENCY; HELMINTHIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; IMMUNITY; INFECTION; KERATINOCYTE; MYCOSIS; NONHUMAN; PHAGOCYTOSIS; PROTOZOAL INFECTION; REVIEW; VIRUS INFECTION; WART VIRUS;

EID: 12344261676     PISSN: 03650596     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0365-05962004000600002     Document Type: Review

References (51)

1. Janeway CA Jr. How the immune system protects the host from infection. Microbes Infect. 2001;3:1167-71.
2. Cooke A, Zaccone P, Raine T, Phillips JM, Dunne DW. Infection and autoimmunity: are we winning the war, only to lose the peace? Trends Parasitol. 2004;20:316-21.
3. Pasare C, Medzhitov R. Toll-like receptors and acquired immunity. Semin Immunol. 2004;16:23-6.
4. Debenedictis C, Joubeh S, Zhang G, Barria M, Ghohestani RF. Immune functions of the skin. Clin Dermatol. 2001;19:573-85.
5. Romani N, Holzmann S, Tripp CH, Koch F, Stoitzner P. Langerhans cells - dendritic cells of the epidermis. APMIS. 2003;111:725-40.
6. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145-73.
7. Mills KH, McGuirk P. Antigen-specific regulatory T cells-their induction and role in infection. Semin Immunol. 2004;16:107-17.
8. Britton WJ, Lockwood DNJ. Leprosy. The Lancet. 2004;363:1209-19.
9. Goulart IMB, Penna GO, Cunha G. Imunopatologia da hanseniase: a complexidade dos mecanismos da resposta imune do hospedeiro ao Mycobacterium leprae. Rev Bras Med Trop. 2002, 35:365-75.
10. Naafs B. Leprosy reactions. New knowledge. Trop Geogr Med. 1994;46:80-4.
11. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med. 1993;177:1675-80.
12. Sarno EN, Grau GE, Vieira LM, Nery JA. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states. Clin Exp Immunol. 1991;84:103-8.
13. Yamamura M, Wang XH, Ohmen JD, Uyemura K, Rea TH, Bloom BR, et al. Cytokine patterns of immunologically mediated tissue damage. J Immunol. 1992;149:1470-5.
14. Foss NT. Aspectos imunológicos da hanseniase. Medicina (Ribeirão Preto) 1999;30:335-9.
15. Modlin RL, Melancon-Kaplan J, Young SMM, Pirmez C, Kino H, Convit J, et al. Learning from lesions: patterns of tissue inflammation in leprosy. Proc Natl Acad Sci USA. 1988;85:1213-7.
16. Barrington R, Zhang M, Fischer M, Carroll MC. The role of complement in inflammation and adaptive immunity. Immunol Rev. 2001;180:5-15.
17. Dong VM, McDermott DH, Abdi R. Chemokines and diseases. Eur J Dermatol. 2003;13:224-30.
18. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med. 1993;177:1199-204.
19. Bacharier LB, Geha RS. Molecular mechanisms of IgE regulation. J Allergy Clin Immunol. 2000;105:S547-58.
20. Caille V, Bossi P, Grimaldi D, Vieillard-Baro A. Physiopathology of severe sepsis. Presse Med. 2004;33:256-61.
21. Chadha KC, Ambrus JL Jr, Dembinski W, Ambrus JL Sr. Interferons and interferon inhibitory activity in disease and therapy. Exp Biol Med. 2004;229:285-90.
22. Kedzierska K, Crowe SM. Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother. 2001;12:133-50.
23. Barmak K, Harhaj EW, Wigdahl B. Mediators of central nervous system damage during the progression of human T-cell leukemia type I-associated myelopathy/tropical spastic paraparesis. J Neurovirol. 2003;9:522-9.
24. Porto AF, Neva FA, Bittencourt H, Lisboa W, Thompson R, Alcântara L, Carvalho EM. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiases. Parasite Imunol. 2001;23:503-07.
25. Porto MA, Muniz A, Oliveira Junior J, Carvalho EM. Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis. Rev Soc Bras Med Trop. 2002;35:641-9.
26. Pfister H, Ter Schegget J. Role of HPV in cutaneous premalignant and malignant tumors. Clin Dermatol. 1997;15:335-47.
27. Dillner L, Bekassy Z, Jonsson N, Moreno-Lopez J, Blomberg J. Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia. Int J Cancer. 1989;43:36-40.
28. Dillner L, Fredriksson A, Persson E, Forslund O, Hansson BG, Dillner J. Antibodies against papillomavirus antigens in cervical secretions from condyloma patients. J Clin Microbiol. 1993;31:192-7.
29. Lee BN, Follen M, Shen DY, Malpica A, Adler-Storthz K, Shearer WT, et al. Depressed type 1 cytokine synthesis by super-antigen-activated CD4+ T cells of women with human papillomavirus-related high-grade squamous intraepithelial lesions. Clin Diagn Lab Immunol. 2004;11:239-44.
30. Zambrano-Villa S, Rosales-Borjas D, Carrero JC, Ortiz-Ortiz L. How protozoan parasites evade the immune response. Trends Parasitol. 2002;18:272-8.
31. Ventura-Juarez J, Jarillo-Luna RA, Fuentes-Aguilar E, Pineda-Vazquez A, Munoz-Femandez L, Madrid-Reyes JI, et al. Human amoebic hepatic abscess: in situ interactions between trophozoites, macrophages, neutrophils and T cells. Parasite Immunol 2003;25:503-11.
32. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun. 2003;71:1185-93.
33. Artavanis-Tsakonas K, Tongren JE, Riley EM. The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin Exp Immunol. 2003;133:145-52.
34. Ribeiro de Jesus A, Almeida RP, Lessa H, Bacellar O, Carvalho EM. Cytokine profile and pathology in human leishmaniasis. Braz. J. Med. Biol. Res. 1998;31:143-8.
35. Machado P, Araujo C, Da Silva AT, Almeida RP, D'Oliveira Jr A, Bittencourt A, et al. Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer. Clin Infect Dis. 2002;34:E69-73.
36. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceição- Silva F, Modlin RL. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest. 1993;91:1390-5.
37. Lessa HA, Machado P, Lima F, Cruz AA, Bacellar O, Guerreiro J, et al. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am J Trop Med Hyg. 2001;65:87-9.
38. Romani L. Immunity to fungal infections. Nat Rev Immunol. 2004;4:1-23.
39. Lilic D. New perspectives on the immunology of chronic mucocutaneous candidiasis. Curr Opin Infect Dis. 2002;15:143-7.
40. Carvalho LP, Bacellar O, Neves N, de Jesus AR, Carvalho EM. Downregulation of IFN-gamma production in patients with recurrent vaginal candidiasis. J Allergy Clin Immunol. 2002;109:102-5.
41. Moraes PS, de Lima Goiaba S, Taketomi EA. Candida albicans allergen immunotherapy in recurrent vaginal candidiasis. J Investig Allergol Clin Immunol. 2000;10:305-9.
42. Pina A, Valente-Ferreira RC, Molinari-Madlum EE, Vaz CA, Keller AC, Calich VL. Absence of interleukin-4 determines less severe pulmonary paracoccidioidomycosis associated with impaired Th2 response. Infect Immun. 2004;72:2369-78.
43. Neva FA, Brown HW. Basic clinical parasitology. Appleton & Lange; 1994. p. 107-144.
44. Else KJ, Finkelman FD. Intestinal nematode parasites, cytokines and effector mechanisms. Int J Parasitol. 1998;28:1145-58.
45. Demeure CE, Rihet P, Abel L, Ouattara M, Bourgois A, Dessein AJ. Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J Infect Dis. 1993;168:1000-8.
46. MacDonald A, Araujo MI, Pearce EJ. Immunology of parsitic helminth infection. Infect Immun. 2002;70:427-33.
47. Finkelman FD, Shea-Donohue T, Goldhill J, Sullivan CA, Morris SC, Madden KB, Gause WC, Urban JF Jr. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu Rev Immunol. 1997;15:505-33.
48. Butterworth AE. Immunological aspects of human schistosomiasis. Br Med Bull. 1998;54:357-68.
49. Grzych JM, Pearce E, Cheever A, Caulada ZA, Caspar P, Heiny S, et al. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J Immunol. 1991;146:1322-7.
50. Araujo MI, de Jesus AR, Bacellar O, Sabin E, Pearce E, Carvalho EM. Evidence of a T helper type 2 activation in human schistosomiasis. Eur J Immunol. 1996;26:1399-403.
51. Malaquias LC, Falcão PL, Silveira AM, Gazzinelli G, Prata A, Coffman RL, et al. Cytokine regulation of human immune response to Schistosoma mansoni: analysis of the role of IL-4, IL-5 and IL-10 on peripheral blood mononuclear cell responses. Scand J Immunol. 1997;46:393-8.